Literature DB >> 9826699

Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

M Valés-Gómez1, H T Reyburn, R A Erskine, J Strominger.   

Abstract

Natural killer (NK) cell cytotoxicity is regulated in large part by the expression of NK cell receptors able to bind class I major histocompatibility complex glycoproteins. The receptors associated with recognition of HLA-C allospecificities are the two-domain Ig-like molecules, p50 and p58 proteins, with highly homologous extracellular domains but differing in that they have either an activating or inhibitory function, respectively, depending on the transmembrane domain and cytoplasmic tails that they possess. We have compared the binding to HLA-Cw7 of an inhibitory p58 molecule, NKAT2, the highly homologous activating p50 molecule, clone 49, and a second activating p50 molecule, clone 39, which has homologies to both NKAT1 and NKAT2. NKAT2 binds to HLA-Cw7 with very rapid association and dissociation rates. However, the p50 receptors bind only very weakly, if at all, to HLA-C. The molecular basis of this difference is analyzed, and the functional significance of these observations is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826699      PMCID: PMC24372          DOI: 10.1073/pnas.95.24.14326

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

2.  Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes.

Authors:  J H Phillips; J E Gumperz; P Parham; L L Lanier
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

3.  Allele-specific peptide ligand motifs of HLA-C molecules.

Authors:  K Falk; O Rötzschke; B Grahovac; D Schendel; S Stevanović; V Gnau; G Jung; J L Strominger; H G Rammensee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

4.  A human killer inhibitory receptor specific for HLA-A1,2.

Authors:  C Döhring; D Scheidegger; J Samaridis; M Cella; M Colonna
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

5.  The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.

Authors:  L L Lanier; J E Gumperz; P Parham; I Melero; M López-Botet; J H Phillips
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

6.  Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene.

Authors:  M Colonna; T Spies; J L Strominger; E Ciccone; A Moretta; L Moretta; D Pende; O Viale
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

7.  Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.

Authors:  V Litwin; J Gumperz; P Parham; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

8.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

Authors:  A Moretta; G Tambussi; C Bottino; G Tripodi; A Merli; E Ciccone; G Pantaleo; L Moretta
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

9.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

Authors:  A Moretta; M Vitale; C Bottino; A M Orengo; L Morelli; R Augugliaro; M Barbaresi; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  57 in total

1.  The human natural killer cell immune synapse.

Authors:  D M Davis; I Chiu; M Fassett; G B Cohen; O Mandelboim; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells.

Authors:  Zaheed Husain; Edward Levitan; Charles E Larsen; Nadeem M Mirza; Souhad Younes; Edmond J Yunis; Chester A Alper; Devendra P Dubey
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

Review 3.  The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Authors:  Jeroen van Bergen; Frits Koning
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

4.  Herpesvirus orthologues of CD200 bind host CD200R but not related activating receptors.

Authors:  Lai Shan Kwong; Munir Akkaya; A Neil Barclay; Deborah Hatherley
Journal:  J Gen Virol       Date:  2015-11-04       Impact factor: 3.891

Review 5.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

6.  HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Authors:  José A Campillo; Jorge A Martínez-Escribano; Manuel Muro; Rosa Moya-Quiles; Luis A Marín; Olga Montes-Ares; Natalia Guerra; Paloma Sánchez-Pedreño; José F Frías; José A Lozano; Ana M García-Alonso; M Rocío Alvarez-López
Journal:  Immunogenetics       Date:  2005-12-20       Impact factor: 2.846

7.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Authors:  Noa Stanietsky; Hrvoje Simic; Jurica Arapovic; Amir Toporik; Ofer Levy; Amit Novik; Zurit Levine; Meirav Beiman; Liat Dassa; Hagit Achdout; Noam Stern-Ginossar; Pinhas Tsukerman; Stipan Jonjic; Ofer Mandelboim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

8.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

9.  Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.

Authors:  Daniela Garrido-Rodríguez; Santiago Ávila-Ríos; Claudia García-Morales; Humberto Valenzuela-Ponce; Christopher Ormsby; Helena Reyes-Gopar; Juan Carlos Fernandez-Lopez; Gustavo Reyes-Terán
Journal:  Immunogenetics       Date:  2016-05-30       Impact factor: 2.846

10.  KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

Authors:  Thorsten Graef; Achim K Moesta; Paul J Norman; Laurent Abi-Rached; Luca Vago; Anastazia M Older Aguilar; Michael Gleimer; John A Hammond; Lisbeth A Guethlein; David A Bushnell; Philip J Robinson; Peter Parham
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.